I was just 27 years old, newly engaged and planning my wedding, when I was diagnosed with HER2+ Stage 2 breast cancer. Overnight, my world shifted from picking out flowers and venues to chemotherapy appointments, surgery dates, and a treatment plan that included chemo, surgery, and radiation.

I remember the day vividly: as a time of solidarity with a group of friends, colleagues and survivors. It was a great day, the streets filled with incredible energy and glorious pink accessories, sunglasses, feather boas and countless women, and a few brave men, all joined in a moment of support. I proudly wore that first T-shirt not knowing that 15 years later, I would be more than a supporter—I would also be a survivor of breast cancer.

CBCN had the pleasure of attending the San Antonio Breast Cancer Symposium in December. Below you’ll find the latest research for early-stage breast cancer. Watch out for the latest research on mBC.

This year top researchers, physicians, manufacturers, and patient advocates met in-person and virtually for the annual San Antonio Breast Cancer Symposium. Once again, this conference shared an abundance of new research on breast cancer from around the globe.

Every year clinicians, researchers, patient advocates and industry members head to Texas to share the latest breakthroughs in breast cancer research. It’s a key conference to learn about new treatments or new standards of care for breast cancer patients. Here’s some of the highlights that have the most impact on patient care today: